Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Chapman

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvantM McCaffery, T J Yao, L Williams, et al.
The Journal of Biological Chemistry|February 25, 1981
Synthesis of acetylated human fetal hemoglobinR L Garlick, J R Shaeffer, P B Chapman, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parametersH C Maguire, D Berd, E C Lattime, et al.
Melanoma Research|August 10, 2002
Clinical results using biochemotherapy as a standard of care in advanced melanomaP B Chapman, K S Panageas, L Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanomaR J Soiffer, P B Chapman, C Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigenX Yan, S V Evans, M J Kaminki, et al.
Cancer|November 15, 1993
Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysisM N Sirott, D F Bajorin, G Y Wong, et al.
Global Change Biology|August 14, 2023
Water level drawdown makes boreal peatland vegetation more responsive to weather conditionsEgle Köster, Jack P B Chapman, Janna M Barel, et al.
Cancer|May 1, 1995
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanomaL M Minasian, T J Yao, T A Steffens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyaninP B Chapman, D Morrisey, K S Panageas, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvantM McCaffery, T J Yao, L Williams, et al.
The Journal of Biological Chemistry|February 25, 1981
Synthesis of acetylated human fetal hemoglobinR L Garlick, J R Shaeffer, P B Chapman, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parametersH C Maguire, D Berd, E C Lattime, et al.
Melanoma Research|August 10, 2002
Clinical results using biochemotherapy as a standard of care in advanced melanomaP B Chapman, K S Panageas, L Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanomaR J Soiffer, P B Chapman, C Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1996
Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigenX Yan, S V Evans, M J Kaminki, et al.
Cancer|November 15, 1993
Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysisM N Sirott, D F Bajorin, G Y Wong, et al.
Global Change Biology|August 14, 2023
Water level drawdown makes boreal peatland vegetation more responsive to weather conditionsEgle Köster, Jack P B Chapman, Janna M Barel, et al.
Cancer|May 1, 1995
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanomaL M Minasian, T J Yao, T A Steffens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyaninP B Chapman, D Morrisey, K S Panageas, et al.
Pageof 5